Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

Active Trials

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Conmana (icotinib) / Betta Pharma

ICTAN, NCT01996098: Icotinib Following Chemotherapy Versus Chemotherapy as Adjuvant Therapy in Stage IIA-IIIA NSCLC With EGFR Mutation

Recruiting

318

RoW

6-month Icotinib, BPI-2009, Conmana, 12-month icotinib

Sun Yat-sen University

Lung Cancer

01/20

01/23

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites